ICCC
NASDAQStockImmuCell Corporation
$6.45-0.18 (-2.71%)
52-Week Range
$4.56
$7.60
Key Stats
Market Cap
—
P/E Ratio
—
Dividend Yield
—
Beta
0.30
Volume
16.9K
Avg Volume
11.7K
Performance
1M
+0.15%
3M
+7.98%
6M
+11.43%
YTD
+11.99%
1Y
+32.87%
3Y
+32.60%
5Y
-36.86%
Price Chart
ETF Exposure
ICCC is held by 13 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| IWC | iShares Micro-Cap ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.00% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| DFAT | Dimensional - US Targeted Value ETF | 0.00% |
| DFSU | Dimensional - US Sustainability Core 1 ETF | 0.00% |
| DXUV | Dimensional - US Vector Equity ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
About ICCC ETF Exposure
ImmuCell Corporation (ICCC) is held by 13 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $6.45. Investors can gain exposure to ICCC through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ICCC, sorted by portfolio weight.